Surface representation of SARS CoV-2 Mpro protein with fragment hits from Diamond XChem platform bound in active site (Green). Credit: Diamond Light Source Ltd
In a new study, researchers from IBM, Oxford University and Diamond Light Source show that IBM’s AI Model, MoLFormer, can generate antiviral molecules for multiple target virus proteins, including SARS-CoV-2, that can accelerate the drug discovery process and bolster our response to future pandemics.
The results are laid out in a new paper published in Science Advances, and at the time of the paper’s submission, the antiviral properties of eleven molecules were successfully validated by Oxford researchers. This breakthrough has the potential to get drugs to people faster in